Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hellerup
SEC filing record 1 source field available
Fiscal year end
31 December
Ascendis Pharma A/S has filed 772 SEC EDGAR filings since 01 Aug 2014

SEC filing history

Showing 176-200 of 772 matching filings.

Per page
25
Current page
8
6-K File 001-36815

6-K

Filing date
12 Dec 2024
Reporting date
12 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
11 Dec 2024
Reporting date
11 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
03 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
19 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
14 Nov 2024
Reporting date
14 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

JANUS AMENDMENT

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

ASCENDIS PHARMA A/S

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
13 Nov 2024
Reporting date
13 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

SC 13G/A

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

SEC SCHEDULE 13G

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
04 Nov 2024
Reporting date
04 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
09 Oct 2024
Reporting date
09 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
30 Sep 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
27 Sep 2024
Reporting date
27 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
23 Sep 2024
Reporting date
23 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .